Ocata Therapeutics Inc fka OCAT

[lasers]

$ACTCD 52 wk high is $10.30 and certainly within reach near term.

FDA approval for ARGUSII Bionic Eye and the Insurance company agreement to pay for the $150K surgery all with very little benefit bodes well for $ACTCD's BLA Commercially approval for both AMD and SMD by both FDA in USA and MHRA in UK. $ACTCD's expected $2000 to $3000 cost for each eye is OOM the preferred way by Ophthalmologists following BLA approvals